0001398659-22-000011.txt : 20220506 0001398659-22-000011.hdr.sgml : 20220506 20220505161858 ACCESSION NUMBER: 0001398659-22-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220505 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220505 DATE AS OF CHANGE: 20220505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genpact LTD CENTRAL INDEX KEY: 0001398659 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 980533350 STATE OF INCORPORATION: D0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33626 FILM NUMBER: 22896600 BUSINESS ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 BUSINESS PHONE: 4412952244 MAIL ADDRESS: STREET 1: CANON'S COURT STREET 2: 22 VICTORIA STREET CITY: HAMILTON STATE: D0 ZIP: HM 12 8-K 1 g-20220505.htm 8-K g-20220505
0001398659FALSE00013986592022-05-052022-05-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 5, 2022
GENPACT LIMITED
(Exact name of registrant as specified in its charter)
Bermuda     001-3362698-0533350
(State or other jurisdiction
of incorporation)
   (Commission
     File Number)
(I.R.S. Employer
Identification No.)
Canon's Court, 22 Victoria Street
Hamilton HM 12, Bermuda
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (441298-3300
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each classTrading SymbolName of each exchange on which registered
Common shares, par value $0.01 per shareGNew York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02Results of Operations and Financial Condition.
On May 5, 2022, Genpact Limited (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2022.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

Item 9.01.Financial Statements and Exhibits.
(d)Exhibits:
 
Exhibit 99.1  
Exhibit 104 
Cover Page Interactive Data File (embedded within the Inline XBRL document)



Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  GENPACT LIMITED
     
Date: May 5, 2022 By: /s/ Heather D. White
  Name: Heather D. White
  Title: Senior Vice President, Chief Legal Officer and Secretary

EX-99.1 2 genpactltdexhibit9912.htm EX-99.1 Document
Exhibit 99.1
image.jpg
Genpact Reports First Quarter 2022 Results
Total Revenue of $1.1 billion, Up 13% (14% on a constant currency basis)1
Global Client Revenue of $973 million, Up 14% (15% on a constant currency basis)1
Diluted EPS of $0.51, Up 9%; Adjusted Diluted EPS2 of $0.60, Up 2%
NEW YORK, May 5, 2022 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced financial results for the first quarter ended March 31, 2022.

“We had a great start to the year with top-line growth, adjusted operating income margin, and adjusted diluted EPS all coming in ahead of our initial expectations,” said “Tiger” Tyagarajan, Genpact’s president and CEO. “Our investments in our strategic choices have positioned us well to help clients navigate the many challenges in this macro environment. We saw another quarter of strong demand for our analytics, digital, and consulting businesses that make up Transformation Services, as well as continued strength in our Intelligent Operations business.”

Key Financial Highlights – First Quarter 2022
Total revenue was $1.1 billion, up 13% year-over-year (14% on a constant currency basis).1
Revenue from Global Clients was $973 million, up 14% year-over-year (15% on a constant currency basis),1 representing 91% of total revenue.
Revenue from GE businesses was $95 million, up 2% year-over-year, representing 9% of total revenue.
Net income was $96 million, up 5% year-over-year, with a corresponding margin of 9.0%.
Income from operations was $134 million, up 5% year-over-year, with a corresponding margin of 12.5%. Adjusted income from operations was $160 million, down 2% year-over-year, with a corresponding margin of 15.0%.3
Diluted earnings per share was $0.51, up 9% year-over-year, and adjusted diluted earnings per share2 was $0.60, up 2% year-over-year.
Cash utilized in operations was $114 million, compared to $77 million generated from operations during the first quarter of 2021.
Genpact repurchased approximately 1.6 million of its common shares during the quarter for total consideration of approximately $76 million at an average price per share of $46.61.
1 Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.
2 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.
3 Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income to adjusted income from operations and GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin are attached to this release.



Full Year 2022 Outlook

Genpact now expects:
Total revenue in the range of $4.325 billion to $4.4 billion, up 8.0% to 9.0%, or 9.0% to 11.0% on a constant currency basis, increased from the prior full-year outlook of $4.3 billion to $4.4 billion, up 7.0% to 9.0%, or 8.0% to 10.0% on a constant currency basis.1 The full-year revenue outlook now assumes an additional adverse impact from foreign currency (at current exchange rates) compared to the outlook given at the beginning of the year.
Global Client revenue growth in the range of 9.0% to 11.0%, or 11.0% to 13.0% on a constant currency basis,1 increased from the prior outlook of 8.0% to 11.0%, or 9.0% to 12.0% on a constant currency basis.1
Adjusted diluted EPS4 of $2.60 to $2.76, increased from the prior outlook of $2.53 to $2.71.
Genpact continues to expect:
Adjusted income from operations margin5 of 16.0% to 16.5%.
Conference Call to Discuss Financial Results
Genpact’s management will host an hour-long conference call beginning at 4:30 p.m. ET on May 5, 2022 to discuss the company’s performance for the first quarter ended March 31, 2022. To participate, callers can dial +1 (877) 654-0173 from within the U.S. or +1 (281) 973-6289 from any other country. Callers will be prompted to enter the conference ID, 8898149. A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the Genpact website after the end of the call. A transcript of the call will also be made available on the website.

About Genpact
Genpact (NYSE: G) is a global professional services firm that makes business transformation real. Led by our purpose -- the relentless pursuit of a world that works better for people -- we drive digital-led innovation and digitally enabled intelligent operations for our clients. Guided by our experience reinventing and running thousands of processes for hundreds of clients, many of them Global Fortune 500 companies, we drive real-world transformation at scale. We think with design, dream in digital, and solve problems with data and analytics. Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details – all 100,000+ of us. From New York to New Delhi, and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent the ways companies work. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we’ll be there with you – accelerating digital transformation to create bold, lasting results – because transformation happens here.
4 Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of the outlook for GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.
5 Adjusted income from operations margin is a non-GAAP measure. A reconciliation of the outlook for each of GAAP income from operations margin and GAAP net income margin to adjusted income from operations margin is attached to this release.




Safe Harbor
This press release contains certain statements concerning our future growth prospects, including our outlook for 2022, financial results and other forward-looking statements, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those in such forward-looking statements. These risks, uncertainties, and other factors include but are not limited to the impact of the invasion of Ukraine by Russia and the related sanctions and other measures being implemented or imposed in response thereto, as well as any potential expansion or escalation of the conflict or its economic disruption beyond its current scope, wage increases in locations in which we have operations, our ability to attract and retain skilled professionals, general inflationary pressures and our ability to share increased costs with our clients, our ability to effectively price our services and maintain pricing and employee utilization rates, the impact of the COVID-19 pandemic on our business and on our employees, clients, partners and suppliers, a slowdown in the economies and sectors in which our clients operate, a slowdown in the business process outsourcing or information technology services sectors, our ability to develop and successfully execute our business strategies, the risks and uncertainties arising from our past and future acquisitions, our ability to convert bookings to revenues, our ability to manage growth, factors which may impact our cost advantage, changes in tax rates and tax legislation and other laws and regulations, risks and uncertainties regarding fluctuations in our earnings, foreign currency fluctuations, general economic conditions affecting our industry, political, economic or business conditions in countries in which we operate, including the withdrawal of the United Kingdom from the European Union, commonly known as Brexit, as well as other risks detailed in our reports filed with the U.S. Securities and Exchange Commission, including Genpact's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available at www.sec.gov. Genpact may from time to time make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. Although Genpact believes that these forward-looking statements are based on reasonable assumptions, you are cautioned not to put undue reliance on these forward-looking statements, which reflect management's current analysis of future events and should not be relied upon as representing management's expectations or beliefs as of any date subsequent to the time they are made. Genpact undertakes no obligation to update any forward-looking statements that may be made from time to time by or on behalf of Genpact.
Contacts
 
Investors  Roger Sachs, CFA
  
+1 (203) 808-6725
  
roger.sachs@genpact.com
Media
Siya Belliappa
 +1 (718) 561-9843
  
siya.belliappa@genpact.com




GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets
(Unaudited)
(In thousands, except per share data and share count)


As of December 31, 2021As of March 31, 2022
Assets
Current assets
Cash and cash equivalents$899,458$861,760
Accounts receivable, net of allowance for credit losses of $24,329 and $21,938 as of December 31, 2021 and March 31, 2022, respectively887,742971,361
Prepaid expenses and other current assets134,441151,613
Total current assets$1,921,641$1,984,734

Property, plant and equipment, net215,089202,707
Operating lease right-of-use assets270,603253,568
Deferred tax assets106,32299,079
Intangible assets, net169,635154,149
Goodwill1,731,0271,722,012
Contract cost assets238,794234,772
Other assets, net of allowance for credit losses of $3,711 and $3,272 as of December 31, 2021 and March 31, 2022, respectively322,158320,250
Total assets$4,975,269$4,971,271
Liabilities and equity
Current liabilities
Short-term borrowings$$250,000
Current portion of long-term debt383,433383,569
Accounts payable24,98421,098
Income taxes payable47,35353,212
Accrued expenses and other current liabilities791,440615,918
Operating leases liability61,59159,497
Total current liabilities$1,308,801$1,383,294
Long-term debt, less current portion1,272,4761,264,372
Operating leases liability247,707229,776
Deferred tax liabilities3,9423,613
Other liabilities245,210242,822
Total liabilities$3,078,136$3,123,877
Shareholders' equity
Preferred shares, $0.01 par value, 250,000,000 authorized, none issued
Common shares, $0.01 par value, 500,000,000 authorized, 185,336,357 and 185,072,415 issued and outstanding as of December 31, 2021 and March 31, 2022, respectively1,8471,845
Additional paid-in capital1,717,1651,693,854
Retained earnings732,474729,503
Accumulated other comprehensive income (loss)(554,353)(577,808)
Total equity$1,897,133$1,847,394
Total liabilities and equity$4,975,269$4,971,271




GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income
(Unaudited)
(In thousands, except per share data and share count)


Three months ended March 31,
20212022
Net revenues$946,071 $1,068,443
Cost of revenue600,928 685,962
Gross profit$345,143 $382,481
Operating expenses:
Selling, general and administrative expenses200,732 237,296
Amortization of acquired intangible assets16,176 11,306
Other operating (income) expense, net353 3
Income from operations$127,882 $133,876
Foreign exchange gains (losses), net3,293 4,303
Interest income (expense), net(12,342)(12,088)
Other income (expense), net1,392 (409)
Income before income tax expense$120,225 $125,682
Income tax expense28,952 29,503
Net income$91,273$96,179
Earnings per common share
Basic$0.48$0.52 
Diluted$0.47$0.51 
Weighted average number of common shares used in computing earnings per common share
Basic188,650,112 185,637,776 
Diluted193,213,258 189,558,404 




GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Cash Flows
(Unaudited)
(In thousands)
Three Months ended March 31,
20212022
Operating activities
Net income$91,273 $96,179 
Adjustments to reconcile net income to net cash (used for)/ provided by operating activities:
Depreciation and amortization28,953 24,847 
Amortization of debt issuance costs557 690 
Amortization of acquired intangible assets16,176 11,306 
Write-down of intangible assets and property, plant and equipment836 — 
Allowance for credit losses727 (463)
Unrealized gain on revaluation of foreign currency asset/liability(3,127)(4,599)
Stock-based compensation expense 17,430 15,250 
Deferred tax expense31 4,914 
Others, net201 19 
Change in operating assets and liabilities:
Increase in accounts receivable(6,385)(83,548)
(Increase) decrease in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets14,526 (4,120)
Increase (decrease) in accounts payable7,700 (2,010)
Decrease in accrued expenses, other current liabilities, operating lease liabilities and other liabilities(106,727)(179,186)
Increase in income taxes payable14,985 6,440 
Net cash (used for)/ provided by operating activities$77,156 $(114,281)
Investing activities
Purchase of property, plant and equipment(12,010)(16,744)
Payment for internally generated intangible assets (including intangibles under development)(1,897)(1,065)
Proceeds from sale of property, plant and equipment681 43 
Payment for business acquisitions, net of cash acquired(5,309)— 
Net cash used for investing activities$(18,535)$(17,766)
Financing activities
Repayment of finance lease obligations(3,037)(2,292)
Payment of debt issuance costs(1,893)— 
Proceeds from long-term debt350,000 — 
Repayment of long-term debt(8,500)(8,500)
Proceeds from short-term borrowings— 250,000 
Repayment of short-term borrowings(250,000)— 
Proceeds from issuance of common shares under stock-based compensation plans6,596 3,300 
Payment for net settlement of stock-based awards(28,721)(41,889)
Dividend paid(20,115)(23,134)
Payment for stock repurchased and retired (including expenses related to stock repurchase)(134,218)(76,032)
Net cash (used for)/ provided by financing activities$(89,888)$101,453 
Effect of exchange rate changes(5,171)(7,104)
Net decrease in cash and cash equivalents(31,267)(30,594)
Cash and cash equivalents at the beginning of the period680,440 899,458 
Cash and cash equivalents at the end of the period$644,002 $861,760 
Supplementary information
Cash paid during the period for interest$4,086 $1,893 
Cash paid during the period for income taxes, net of refund$21,988 $28,580 




Non-GAAP Financial Measures

To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:

Adjusted income from operations;
Adjusted income from operations margin;
Adjusted diluted earnings per share; and
Revenue growth on a constant currency basis.

These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of Genpact’s GAAP financial statements to such non-GAAP financial measures should be carefully evaluated.

Prior to July 2012, Genpact’s management used financial statements that excluded significant acquisition-related expenses, amortization of related acquired intangibles, and amortization of acquired intangibles recorded at the company’s formation in 2004 for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to that of its competitors. However, considering Genpact’s acquisitions of varying scale and size, and the difficulty in predicting expenses relating to acquisitions and the amortization of acquired intangibles thereof, since July 2012 Genpact’s management has used financial statements that exclude all acquisition-related expenses and amortization of acquired intangibles for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to those of its competitors. For the same reasons, since April 2016 Genpact’s management has excluded the impairment of acquired intangible assets from the financial statements it uses for internal management purposes. Acquisition-related expenses are excluded in the period in which an acquisition is consummated.

Genpact’s management also uses financial statements that exclude stock-based compensation expense. Because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use when adopting ASC 718 “Compensation-Stock Compensation,” Genpact’s management believes that providing non-GAAP financial measures that exclude such expenses allows investors to make additional comparisons between Genpact’s operating results and those of other companies. Additionally, in its calculations of non-GAAP financial measures, Genpact’s management has adjusted foreign exchange gains and losses, interest income and expense and income tax expenses from GAAP net income, and other income and expenses, and certain gains, losses and impairment charges attributable to equity-method investments from GAAP income from operations, because management believes that the Company’s results after taking into account these adjustments more accurately reflect the Company’s ongoing operations. In its calculations of adjusted diluted earnings per share, Genpact’s management adds back adjusted stock-based compensation expense, amortization and impairment of acquired intangible assets, acquisition-related expenses and the related tax impact of such adjustments from GAAP diluted earnings per share. For the purpose of calculating adjusted diluted earnings per share, the combined current and deferred tax effect is determined by multiplying each pre-tax adjustment by the applicable statutory income tax rate.

Genpact’s management provides information about revenues on a constant currency basis so that the revenues may be viewed without the impact of foreign currency exchange rate fluctuations compared to prior fiscal periods, thereby facilitating period-to-period comparisons of the Company’s true business performance. Revenue growth on a constant currency basis is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.

Accordingly, Genpact believes that the presentation of adjusted income from operations, adjusted income from operations margin, adjusted diluted earnings per share and revenue growth on a constant currency basis, when read in conjunction with the Company’s reported results, can provide useful supplemental information to investors and management regarding financial and business trends relating to its financial condition and results of operations.

A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income and net income margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation expense and amortization and impairment of acquired intangible assets. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.




The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the three months ended March 31, 2021 and 2022:
Reconciliation of Net Income/Margin to Adjusted Income from Operations/Margin
(In thousands)

Three months ended March 31,
2021 2022
Net income$91,273$96,179
Foreign exchange (gains) losses, net(3,293)(4,303)
Interest (income) expense, net12,34212,088
Income tax expense28,95229,503
Stock-based compensation expense17,43015,250
Amortization and impairment of acquired intangible assets15,95211,302
Adjusted income from operations$162,656$160,019
Net income margin9.6 %9.0 %
Adjusted income from operations margin17.2 %15.0 %
    
    
Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin
(In thousands)

Three months ended March 31,
2021 2022
Income from operations$127,882$133,876
Stock-based compensation expense17,43015,250
Amortization and impairment of acquired intangible assets15,95211,302
Other income (expense), net1,392(409)
Adjusted income from operations$162,656$160,019
Income from operations margin13.5 %12.5 %
Adjusted income from operations margin17.2 %15.0 %




Reconciliation of Diluted EPS to Adjusted Diluted EPS6
(Per share data) 

Three months ended March 31,
2021 2022
Diluted EPS$0.47 $0.51
Stock-based compensation expense0.090.08
Amortization and impairment of acquired intangible assets0.080.06
Tax impact on stock-based compensation expense(0.03)(0.03)
Tax impact on amortization and impairment of acquired intangible assets(0.02)(0.01)
Adjusted diluted EPS$0.59$0.60


6 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.




The following tables show the reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP measures for the year ending December 31, 2022:

Reconciliation of Outlook for Net Income Margin to Adjusted Income from Operations Margin7

Year ending December 31, 2022
LowerUpper
Net income margin9.4%9.8%
Estimated foreign exchange (gains) losses, net(0.1)%(0.1)%
Estimated interest (income) expense, net1.0%1.0%
Estimated income tax expense3.0%3.1%
Estimated stock-based compensation expense1.7%1.6%
Estimated amortization of acquired intangible assets1.0%1.0%
Adjusted income from operations margin16.0%16.5%


Reconciliation of Outlook for Income from Operations Margin to Adjusted Income from
Operations Margin7


Year ending December 31, 2022
LowerUpper
Income from operations margin13.3%13.8%
Estimated stock-based compensation expense1.7%1.6%
Estimated amortization and impairment of acquired intangible assets1.0%1.0%
Estimated other income (expense), net0.1%0.1%
Adjusted income from operations margin16.0%16.5%

Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS7
(Per share data)

Year ending December 31, 2022
LowerUpper
Diluted EPS$2.14 $2.30 
Estimated stock-based compensation expense0.390.39
Estimated amortization and impairment of acquired intangible assets0.230.23
Estimated tax impact on stock-based compensation expense(0.10)(0.10)
Estimated tax impact on amortization and impairment of acquired intangible assets(0.06)(0.06)
Adjusted diluted EPS$2.60 $2.76 

7 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.


EX-101.SCH 3 g-20220505.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 g-20220505_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag Written Communications Written Communications City Area Code City Area Code Title of 12(b) Security Title of 12(b) Security Security Exchange Name Security Exchange Name Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Cover [Abstract] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Country Entity Address, Country Entity Address, Address Line Two Entity Address, Address Line Two Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key Trading Symbol Trading Symbol EX-101.PRE 5 g-20220505_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image.jpg begin 644 image.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
May 05, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 05, 2022
Entity Registrant Name GENPACT LIMITED
Entity Incorporation, State or Country Code D0
Entity File Number 001-33626
Entity Tax Identification Number 98-0533350
Entity Address, Address Line One Canon's Court,
Entity Address, Address Line Two 22 Victoria Street
Entity Address, City or Town Hamilton
Entity Address, Postal Zip Code HM 12
Entity Address, Country BM
City Area Code 441
Local Phone Number 298-3300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares, par value $0.01 per share
Trading Symbol G
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001398659
Amendment Flag false
XML 8 g-20220505_htm.xml IDEA: XBRL DOCUMENT 0001398659 2022-05-05 2022-05-05 0001398659 false 8-K 2022-05-05 GENPACT LIMITED D0 001-33626 98-0533350 Canon's Court, 22 Victoria Street Hamilton HM 12 BM 441 298-3300 false false false false Common shares, par value $0.01 per share G NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.genpact.com/role/Cover Cover Cover 1 false false All Reports Book All Reports g-20220505.htm g-20220505.xsd g-20220505_lab.xml g-20220505_pre.xml genpactltdexhibit9912.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "g-20220505.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "g-20220505.htm" ] }, "labelLink": { "local": [ "g-20220505_lab.xml" ] }, "presentationLink": { "local": [ "g-20220505_pre.xml" ] }, "schema": { "local": [ "g-20220505.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "g", "nsuri": "http://www.genpact.com/20220505", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "g-20220505.htm", "contextRef": "ib4d280c127434c3b8dce46f66f982296_D20220505-20220505", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.genpact.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "g-20220505.htm", "contextRef": "ib4d280c127434c3b8dce46f66f982296_D20220505-20220505", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.genpact.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001398659-22-000011-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001398659-22-000011-xbrl.zip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end